Results being prepared for ASCO shows although Ibrutinib is effective, serious diarrhea complications makes it difficult to complete therapy without medical intervention by investigators. Ibrutinib market due to its side effects may be much smaller than previously anticipated since side effects may limit its therapeutic effectiveness. A therapy that cannot be tolerated efficacy rate does not matter. You have 48 hours advance warning.
Best of luck
Libelous statement. Additionally, you state you have insider knowledge of embargoed materials which you are disseminating for public consumption. If you are an insider, you violate company policy, and SEC insider trading statutes. If you are not, your masquerading as a company employee is illegal. Reported to Yahoo, and to the company.